CSFB launches $75m High Medical IPO

Premarketing got underway today (Wednesday) for the $75m IPO of Swiss medical devices manufacturer High Medical Technologies.

  • 09 Mar 2001
Email a colleague
Request a PDF
The company, which specialises in equipment for urology and orthopaedics departments, will list on the SWX New Market. Credit Suisse First Boston is sole bookrunner for the deal.

The company is planning to sell 390m shares in the base offering and 59m in the greenshoe. The total offering represents 53% of the company. The price range for the deal will be announced on March 26.

Of the issue, about half will be capital increase and half will be secondary. "The company is going to use the proceeds to finance internal growth, enter further collaboration arrangements and commission scientific and clinical surveys," said a banker close to the deal.

Bank Sarasin, Lombard Odier and Kantonalbank are co-managers.

  • 09 Mar 2001

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 24 Jul 2017
1 Citi 253,106.92 930 8.89%
2 JPMorgan 230,914.50 1036 8.11%
3 Bank of America Merrill Lynch 221,389.46 762 7.78%
4 Goldman Sachs 171,499.26 554 6.03%
5 Barclays 169,046.60 646 5.94%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 25,935.16 104 7.16%
2 Deutsche Bank 25,125.19 81 6.94%
3 Bank of America Merrill Lynch 22,023.57 59 6.08%
4 BNP Paribas 19,315.94 110 5.34%
5 Credit Agricole CIB 18,706.93 106 5.17%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 18 Jul 2017
1 JPMorgan 12,578.87 55 8.17%
2 Citi 11,338.07 71 7.36%
3 UBS 10,682.06 44 6.93%
4 Goldman Sachs 10,419.53 53 6.76%
5 Morgan Stanley 10,194.88 57 6.62%